Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study.
Yasuhiro HagiwawaTakeru ShiroiwaKojiro ShimozumaTakuya KawaharaYukari UemuraTakanori WatanabeNaruto TairaTakashi FukudaYasuo OhashiHirofumi MukaiPublished in: PharmacoEconomics (2019)
C000000416.